Pathogenesis, epidemiology and control of Group A Streptococcus infection | Nature Reviews Microbiology (nature.com/articles/s4157…)

What’s your HbA1c? Because every 1% higher means 20% more heart risk. Anup Singh - Founder CEO dLife Healthcare Pvt Ltd

GLP-1–based drugs aren’t just for diabetes or obesity. 🔥 New JCI review: They also show potent anti-inflammatory effects across heart, kidney, liver, and brain — via both weight-loss–dependent and independent pathways. ➡️ Beyond glucose control: GLP-1 therapies lower

The APOE4 allele, present in >20% of the population, is a significant risk marker for #Alzheimers. What if we could flip it to the protective APOE2 allele? Encouraging results in the experimental model nature.com/articles/s4159… nature.com/articles/s4159…

The potency of the GLP-1 drugs for weight loss keeps increasing. Retatrutide is a triple receptor agonist with no clearcut plateau. There are already quadruple receptors in the pipeline. economist.com/the-world-ahea…